Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Donohoe

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2010
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophreniaG Spalletta, D W Morris, F Angelucci, et al.
Molecular Psychiatry|October 16, 2013
Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disordersE M Kenny, P Cormican, S Furlong, et al.
Neuroscience Letters|September 18, 2012
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137E Cummings, G Donohoe, A Hargreaves, et al.
Translational Psychiatry|January 25, 2017
MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controlsD Cosgrove, D Harold, O Mothersill, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 12, 2007
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sampleA Corvin, K A McGhee, K Murphy, et al.
Analytica Chimica Acta|May 21, 2013
At-line bioprocess monitoring by immunoassay with rotationally controlled serial siphoning and integrated supercritical angle fluorescence opticsCharles E Nwankire, Gerard G Donohoe, Xin Zhang, et al.
Molecular Psychiatry|April 30, 2014
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disabilityS E McCarthy, J Gillis, M Kramer, et al.
Genes, Brain, and Behavior|January 17, 2013
Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253G Donohoe, J Walters, A Hargreaves, et al.
Molecular Psychiatry|August 21, 2013
Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility geneX-J Luo, M Li, L Huang, et al.
Molecular Psychiatry|December 18, 2013
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT)T Lencz, E Knowles, G Davies, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2010
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophreniaG Spalletta, D W Morris, F Angelucci, et al.
Molecular Psychiatry|October 16, 2013
Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disordersE M Kenny, P Cormican, S Furlong, et al.
Neuroscience Letters|September 18, 2012
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137E Cummings, G Donohoe, A Hargreaves, et al.
Translational Psychiatry|January 25, 2017
MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controlsD Cosgrove, D Harold, O Mothersill, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 12, 2007
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sampleA Corvin, K A McGhee, K Murphy, et al.
Analytica Chimica Acta|May 21, 2013
At-line bioprocess monitoring by immunoassay with rotationally controlled serial siphoning and integrated supercritical angle fluorescence opticsCharles E Nwankire, Gerard G Donohoe, Xin Zhang, et al.
Molecular Psychiatry|April 30, 2014
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disabilityS E McCarthy, J Gillis, M Kramer, et al.
Genes, Brain, and Behavior|January 17, 2013
Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253G Donohoe, J Walters, A Hargreaves, et al.
Molecular Psychiatry|August 21, 2013
Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility geneX-J Luo, M Li, L Huang, et al.
Molecular Psychiatry|December 18, 2013
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT)T Lencz, E Knowles, G Davies, et al.
Pageof 6